Anne Danø

9PUBLICATIONS
19CO-AUTHORS
Animal protection (incl. pests and pathogens)Clinical pharmacy and pharmacy practiceCancer therapy (excl. chemotherapy and radiation therapy)Evolution of developmental systemsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 24, 2026
Real-World Shelf Life of Epinephrine Auto-Injectors in Canada: Implications for Renewal Frequency and Patient Burden.

|May 27, 2026
Real-World Shelf Life of Adrenaline Auto-Injectors at Pharmacies in Denmark, Finland, Sweden, and Norway.

|Sep 19, 2023
Axicabtagene ciloleucel compared to standard of care in Swedish patients with large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial.

Anne Sofie Ledgaard Loftager, Anne Danø, Oskar Eklund

|Aug 03, 2023
The Cost-Effectiveness of Anti-IL17 Biologic Therapies for Moderate-to-Severe Plaque Psoriasis Treatment in Italy and Germany: A Sequential Treatment Analysis.

Nanna Nyholm, Anne Danø, Henrik Schnack

|May 19, 2023
Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany.

Nanna Nyholm, Henrik Schnack, Anne Danø

|Mar 31, 2023
Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.

Mikkel H Pedersen, Anne Danø, Ebbe Englev

Pageof 2

Frequent Collaborators

3 joint publications

Mikkel H Pedersen

2 joint publications

Emma Munk

2 joint publications

Nanna Nyholm

2 joint publications

Henrik Schnack